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Abstract
Background
CKD is associated with several comorbidities, cardiovascular disease being the most signifi-
cant. Aerobic training has a beneficial effect on cardiovascular health in healthy and some
well-defined non-healthy populations. However, the effect of aerobic training on glomerular
filtration rate in patients with CKD stages 3–4 is unclear.
Objective
To review the effects of aerobic exercise training on kidney and cardiovascular function in
patients with chronic kidney disease (CKD) stages 3–4.
Methods
A random-effects meta-analysis was performed to analyse published randomized controlled
trials through February 2018 on the effect of aerobic training on estimated glomerular filtra-
tion rate, blood pressure and exercise tolerance in patients with CKD stages 3–4. Web of
Science, PubMed and Embase databases were searched for eligible studies.
Results
11 randomized controlled trials were selected including 362 participants in total. Favourable
effects were observed on estimated glomerular filtration rate (+2.16 ml/min per 1.73m2;
[0.18; 4.13]) and exercise tolerance (+2.39 ml/kg/min; [0.99; 3.79]) following an on average
35-week aerobic training program when compared to standard care. No difference in
change in blood pressure was found.
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Conclusions
There is a small beneficial effect of aerobic training on estimated glomerular filtration rate
and exercise tolerance, but not on blood pressure, in patients with CKD stages 3–4. How-
ever, data are limited and pooled findings were rated as of low to moderate quality.
Introduction
Patients with chronic kidney disease (CKD) have a high risk to develop cardiovascular (CV)
disease, for which exercise training is known to be a successful preventive strategy [1]. Also,
the probability for death (with CV disease as leading cause) in patients with CKD stages 3–4 is
higher than the probability to progress to end-stage renal disease [2–4]. Therefore alone
already it is useful to stress the utility of exercise training. In addition, most patients suffer of a
severely impaired exercise tolerance and performance, both in themselves predictors of sur-
vival [5]. Underlying mechanisms include renal anaemia, malnutrition, vascular dysfunction
and/or polyneuropathy [6–8]. Consequently, the majority of patients with CKD do not meet
the European Guidelines for physical activity of 150 min/week of moderate intensity (class I,
level of recommendation A) [9]. This creates a vicious circle of worsened exercise intolerance
and physical inactivity further enhancing increased CV risks [10]. Exercise tolerance plays a
pivotal role in reaching recommended physical activity levels, which in turn is essential in the
preservation of functional movement, general well-being and the management of CV risk fac-
tors (e.g. body weight control) in patients without CKD. Exercise training improves exercise
tolerance and allows individuals to increase their physical activity levels. Some evidence sug-
gests a similar beneficial impact in patients with CKD [11]. Primarily patients with CKD stages
3 or worse [4], i.e. when CV risk starts to increase, could potentially benefit from aerobic exer-
cise training [12].
Despite the absence of a consensus on which frequency, intensity, type and time of exercise
is of most benefit, regular exercise increases peak oxygen consumption (VO2peak), improves
blood pressure control, CV risk profile, mental health and health-related Quality of Life in the
entire range of CKD patients [10, 11]. Aerobic exercise, as opposed to anaerobic training, is
assumed to induce systemic changes, possibly affecting determinants of glomerular filtration
rate. However, there is still a knowledge gap concerning the effect of aerobic exercise on esti-
mated glomerular filtration rate. Therefore, an updated meta-analysis can present new insights
on the effects of exercise training with respect to the most recent Cochrane review [11]. In this
meta-analysis, we investigated the effect of aerobic exercise in patients with CKD stages 3–4
through a meta-analysis. The following research questions will be answered: What is the effect
of aerobic exercise on (1) estimated glomerular filtration rate (eGFR) and (2) blood pressure
and VO2peak compared to standard care in patients with CKD stages 3–4?
Materials & methods
Data sources and selection criteria
This systematic search and meta-analysis was performed according to the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [13] and checklist (S1
Checklist). The protocol of this meta-analysis was registered retrospectively on PROSPERO
(registration number: CRD42018103223). Only randomized controlled trails (RCTs) were
included. Following inclusion criteria needed to be fulfilled: (1) adult (>18 years) human
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subjects, (2) mean baseline eGFR of the population between 59 and 15 ml/min per 1.73m2
(CKD stage 3 and 4), (3) aerobic exercise includes the intervention method, (4) intervention
encompassed at least 3 months of training with at least 2 sessions per week and (5) studies had
to be written in Dutch, English, German or French. Non-randomized controlled and observa-
tional trials, reviews, meta-analyses, short communication articles, letters to the editor and
study protocols were excluded. No publication date or other restrictions were imposed. Studies
were searched describing the effect of aerobic exercise compared to standard care on eGFR,
blood pressure or VO2peak in patients with CKD stages 3–4. Three electronic databases were
consulted and searched for eligible papers until February 2018 (i.e. Web of Science, PubMed
and Embase) with a supplementary search on clinicaltrials.gov to identify potential missing tri-
als and to retrieve protocols. Reference lists of included studies were screened for additional
studies. MeSH-terms or keywords used in the search strategy (S1 Table) included: ‘Chronic
Renal Insufficiency’, ‘Chronic Kidney Disease’, ‘Chronic Renal Failure’, ‘Exercise’, ‘Circuit-
Based Exercise’, ‘Rehabilitation’, ‘Aerobic Exercise Training’, ‘Aerobic Exercise’, ‘Exercise
Training’, ‘Glomerular Filtration Rate’, ‘GFR’, ‘Kidney Function’, ‘Renal Function’, ‘Heart
Rate’, ‘Blood Pressure’, ‘Oxygen Consumption’, ‘VO2peak’ and ‘Aerobic Capacity’. Search
strategy, full selection process, screening on title, abstract, full text (Kappa: 0.97), data extrac-
tion and quality assessment were developed and executed in duplicate by 2 independent asses-
sors (VWK and TA, PhD students Rehabilitation Sciences and Physiotherapy, under the
supervision of CP, PhD). Discrepancies were discussed and in case of no unanimous conclu-
sion referred to CP, who had the final decision.
Data extraction and quality assessment
Qualitative (Table 1) and quantitative data were extracted from the included articles. Corre-
sponding authors were addressed to provide missing or tailored data based on our eligibility
criteria (e.g. excluding patients with CKD stage 2). Data for between-groups analyses was
extracted from the results of patient and control group analyses. Body mass index (BMI) was
post hoc included as secondary outcome. Methodological quality of studies was evaluated
according the checklist for assessing risk of bias provided by the Cochrane Collaboration [14].
Quality of evidence and strength of recommendations were assessed by the Grading of Recom-
mendations, Assessment, Development and Evaluations (GRADE) method [15].
Statistical analysis for meta-analysis
The ‘GRADEpro Guideline Development Tool’ and ‘Review Manager 5.3.5’ from the Cochrane
Collaboration were used for quality assessment of evidence and to calculate effect estimates for
combinations of single effects from included studies and to subsequently perform subgroup analy-
ses respectively. Treatment effects were calculated as mean differences in outcomes. If eGFR was
calculated using another equation than the CKD-EPI or Modified Diet in Renal Disease formula
(MDRD), the CKD-EPI formula was applied on mean and standard deviation values of the popu-
lation [16]. The Dersimonian-Laird inverse variance weighted random effects method was used
to pool study findings and heterogeneity was calculated (I2,<25% = no heterogeneity and75%
= high heterogeneity) [17]. Sensitivity analysis was planned and subgroup analyses were per-
formed on changes in eGFR to explore sources of heterogeneity and subgroup variables included:
intervention type (i.e. aerobic exercise vs. resistance and aerobic exercise) and duration, age and
BMI. Age and BMI were categorised based on cut-off points: 60 years old and 32 kg/m2 respec-
tively. Subgroup breakdown for intervention duration was based on duration more or less than 6
months. Results were considered significant at 95% study confidence interval. Forest plots were
used to present findings of the meta-analysis.
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Table 1. Table of evidence and characteristics of included studies.
Study Purpose and primary
outcome
Exercise group Control
group
Intervention Time
frame
Kidney
parameters
Cardiovascular
parameters
Main results
Aoike et al
(2015)
Home-based aerobic
exercise provides
physical and clinical
benefits in OP with
CKD; Primary
outcome a:VO2peak
9♂, 5♀; BMI 31.7
±4.5; GFR 28.4
±11.6; Age 55.9
±7.7
10♂, 5♀;
BMI
30.7
±4.1;
GFR
25.3
±13.4;
Age 54.3
±8.7
Aerobic exercise
training: 3 sessions/
week: 5min warming
up/cooling down;
30min walking at heart
rate at VT 1 obtained in
CPET and spirometry;
+10min each 4 weeks;
At start 3 supervised
sessions
12
Weeks
GFR Heart rate; Blood
pressure; VO2
Increased heart rate at
VT; Decreased heart
rate in rest; Decreased
resting systolic and
diastolic blood pressure;
Improvement GFR;
Improvement peak- and
VT-VO2
Baria et al (2014) Impact of aerobic
exercise on visceral fat
in CKD obese
patients; Primary
outcome a: Reduction
visceral fat
Centre based; 10
♂; BMI 30.8±5.1;
GFR 25.8±8.8;
Age 52.1±11.4—
Home based; 8
♂; BMI 30.9±3.9;
GFR 29.4±11.2;
Age 50.8±7.7
9 ♂;
BMI
29.6
±1.9;
GFR
27.7
±15.0;
Age 53.4
±9.6
Aerobic exercise
training: Centre based,
3 sessions/week: 5min
warming up/cooling
down; 30min walking at
heart rate at VT 1
obtained in CPET and
spirometry; +10min
each 4 weeks—Home
based, 3 sessions/week:
Exercise with uniform
instructions as centre-
based group; +10min
each 4 weeks during
one supervised session
12
Weeks
GFR Blood pressure;
VO2
Improvement GFR and
blood pressure in
centre-based group; No
improvement GFR and
blood pressure in
home-based group; No
improvement VO2peak
Greenwood et al
(2015)
Effects of exercise on
GFR and
cardiovascular
function; Primary
outcome a: eGFR
6♂, 2♀; BMI 27.4
±3.52; GFR 36.6
±10.1; Age 53.8
±13.5
9♂, 1♀;
BMI
28.4
±4.24;
GFR
46.5
±20.6;
Age 53.8
±13
Aerobic and resistance
exercise training: 2
supervised sessions/
week (20min); 1
unsupervised session/
week (40min); 5min
warming up / cooling
down; 80% heart rate
reserve cycling with
maximal heart rate
obtained in CPET; 80%
1RM resistance training
52
Weeks
GFR Blood pressure;
Heart rate; VO2
Improvement mean rate
of change in GFR
compared the 12
months pre-
intervention period; No
between-group change
GFR; No change resting
blood pressure and
heart rate;
Improvement relative
VO2peak; No change
absolute VO2peak
Headley et al
(2012)
Exercise improves
heart rate recovery
and VO2peak in
predialysis kidney
patients; Primary
outcome b: eGFR
10 patients; BMI
32.7±7.2; GFR
33.2±20.1; Age
57.5±11.5
11
patients
BMI
34.2±5.7
GFR
48.5
±23.4;
Age 57.5
±11
Aerobic and resistance
exercise training: 3
supervised sessions/
week:; 5min warming
up/cooling down;
45min at HR at 50–60%
VO2peak obtained in
CPET and spirometry;
Treadmill, cycle,
elliptical machines,
stairmasters; Week 24
to 48: Resistance
training to avoid
boredom
48
Weeks
GFR;
Proteinuria
blood pressure;
Heart rate; VO2
No change in GFR,
creatinine clearance and
proteinuria; No change
in resting ambulatory
blood pressure;
Decreased resting
ambulatory heart rate;
Improvement VO2peak
Headley et al
(2014)
Effects short-term
aerobic exercise on
vascular function in
CKD; Primary
outcome a: Pulse wave
velocity
25 patients; BMI
34.9±8.0; GFR
47.0±12.0; Age
58.0±8.0
21
patients;
BMI
36.5
±8.9;
GFR
48.3
±12.7;
Age 57.1
±9.0
Aerobic exercise
training: 3 supervised
sessions/week: 5min
warming up/cooling
down; 45min at HR at
50–60% VO2peak
obtained in CPET and
spirometry: Treadmill,
cycle, elliptical
machines, stairmasters
16
Weeks
/ Blood pressure No change blood
pressure
(Continued)
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Table 1. (Continued)
Study Purpose and primary
outcome
Exercise group Control
group
Intervention Time
frame
Kidney
parameters
Cardiovascular
parameters
Main results
Howden et al
(2013)
Effect of exercise and
lifestyle intervention
on cardiovascular
function in CKD;
Primary outcome a:
VO2peak
36 patients; BMI
32.5±6.8; GFR
38.4±8.8; Age
60.2±9.7;
36
patients;
BMI
33.0
±8.0;
GFR
39.4
±8.9;
Age 62.0
±8.4
Aerobic and resistance
exercise training: 3
supervised sessions/
week for 8 weeks; 5min
warming up/cooling
down; 30min treadmill,
cycling and rowing at
11–13 on RPE-scale; 3
unsupervised session/
week:; 150min exercise/
week at 11–13 on RPE-
scale
52
Weeks
GFR Blood pressure;
VO2
No change in GFR and
blood pressure;
Improvement VO2peak;
More patients reached
age-predicted exercise
tolerance
Leehey et al
(2009)
Effect of aerobic
exercise in obese
patients with CKD;
Primary outcome b: /
7♂ ; Diabetes
Mellitus type 2 ;
GFR 23.3±12.0 ;
Age 66
4♂ ;
Diabetes
Mellitus
type 2 ;
GFR
30.4
±13.2 ;
Age 66
Aerobic exercise
training: 3 supervised
sessions/week for 6
weeks; 5min warming
up/cooling down; Week
1–3: 6min 25–44%,
18min 45–59% and
6min 60–84% of
VO2peak; Week 4–6:
6min 25–44%, 22min
45–59% and 12min 60–
84% of VO2peak; 3
unsupervised sessions/
week: Increase step
count by 10%/week;
Intensity based on
CPET & spirometry
24
Weeks
GFR;
Proteinuria
Blood pressure;
Heart rate; VO2
Decreased resting
systolic blood pressure,
no effect after follow-
up; No change GFR and
heart rate; Decreased
proteinuria;
Improvement VO2peak;
Tendency improvement
VO2 at isotime (at the
exact same workload)
Leehey et al
(2016)
Exercise in obese
patients with CKD;
Primary outcome a:
Urine protein to
creatinine ratio
14♂; BMI 36.2
±4.8; GFR 41.5
±18.8; Age 65.4
±8.7
18♂;
BMI
37.4
±4.2;
GFR
38.9
±20.3;
Age 66.6
±7.5
Aerobic and resistance
exercise training: 3
supervised sessions/
week for 12 week;
60min interval training
on treadmill, elliptical
machine and cycle at
25–84% HR at VO2peak
obtained in CPET;
30min resistance
training: 3 (60min) or 6
(30min) unsupervised
sessions/week with
similar instructions
52
Weeks
GFR;
Proteinuria
Blood pressure;
VO2
No change GFR and
proteinuria; No change
resting systolic blood
pressure and VO2peak
Miele et al
(2016)
Lipoprotein pattern
and response to
moderate aerobic
exercise in CKD;
Primary outcome b:
HDL-pattern
25 patients; BMI
34.9±8.0; GFR
47±12
21
patients;
BMI
36.5
±8.9;
GFR
48.3
±12.7
Aerobic exercise
training: 3 supervised
sessions/week; 15min to
55min aerobic exercise
50–60% VO2peak
obtained on CPET and
spirometry
16
Weeks
GFR VO2 No change GFR;
Improvement VO2peak
Mustata et al
(2011)
Effects of exercise on
arterial stiffness in
predialysis CKD;
Primary outcome b:/
7♂, 3♀; BMI
27.5; GFR 27±?;
Age 64±4.5
6♂, 4♀;
BMI 29;
GFR 28
±?; Age
72.5±3.5
Aerobic exercise
training: 5 sessions/
week:; 2 supervised + 3
unsupervised sessions;
20min at 40–60%
VO2peak obtained in
CPET:; Treadmill,
cycle, elliptical trainer;
Duration +10% each
week to 60min
52
Weeks
GFR Blood pressure;
VO2
No change in GFR and
blood pressure;
Improvement VO2peak
(Continued)
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Results
Search results
A total of 1038 studies were identified through our database search. After removing duplicates
and two screening phases (title/abstract and full text), 11 studies were withheld based on the
in- and exclusion criteria (Fig 1).
Study characteristics
Depending on the study and following the ‘Kidney Disease Outcomes Quality Initiative’
(KDOQI) guidelines [18], participants presented with stages 2–4 [19–21], 3–4 [22–26] or stage
3 [1, 27, 28] CKD. Four studies had a therapy duration of 6 months or more [1, 19, 24, 25] and
aerobic exercise modalities included: (1) walking [20, 22, 23, 25], (2) cycling [24, 26] or (3) use
of various training-devices like treadmill, cycle ergometer, elliptical machines, stairmasters or
rowing machines [1, 19, 21, 25, 27, 28]. Resistance training was included as intervention in
four studies [1, 19, 21, 24]. Training intensities were monitored based on: (1) heart rate at 90%
[26] or 100% [22, 23] heart rate at ventilatory threshold, (2) percentage of intensity at VO2peak
(i.e. 50–60% [19, 27, 28], 40–60% [25] and 25–84% [20, 21]), (3) heart rate at 80% of heart rate
reserve [24] and (4) Borg Rating of Perceived Exertion scale 11–13 [1].
Quality assessment
Risk for selection and detection bias was unclear in four (36%) [19, 22, 23, 28] and five (45%)
[19, 20, 22, 27, 28] RCTs respectively. Only Leehey et al was scored as high risk for selection
bias due to allocation concealment [20]. Because blinding of participants is an insurmountable
obstacle in exercise intervention RCTs, high risk of detection bias was granted to all RCTs.
Five studies scored unclear risk for reporting bias based on lacking registration on clinical trial
registries [1, 20, 23, 24, 28]. Attrition and the other sources of bias performed better compared
to the aforementioned bias criteria with a low risk in more than 75% of the studies (Fig 2).
Quality of evidence for the eGFR and BMI analyses were rated as of moderate strength deriv-
ing from detection bias (Table 2). Findings of blood pressure and VO2peak were valued of
Table 1. (Continued)
Study Purpose and primary
outcome
Exercise group Control
group
Intervention Time
frame
Kidney
parameters
Cardiovascular
parameters
Main results
Van
Craenenbroeck
et al (2015)
Effect of 12 weeks
home-based exercise
training on
endothelial function
in CKD 3–4; Primary
outcome a: Flow-
mediated dilation
11♂, 8♀; BMI
28.3±6.2; GFR
37.5±13.2; Age
51.5±11.8
11♂,
10♀;
BMI
28.3
±5.8;
GFR
39.6
±12.9;
Age 54.7
±14
Aerobic exercise
training: 4 sessions/day;
10min cycling/session
at 90% heart rate at VT
obtained at CPET and
spirometry; 3
supervised sessions in
week 1–2; 1 supervised
session in week 3–4
12
Weeks
GFR Blood pressure;
VO2
No change in GFR and
blood pressure;
Improvement peak- and
VT-VO2; More P
reaching age-predicted
VO2peak
♀ = Female Patients; ♂ = Male Patients; BMI: Body Mass Index; CG = Control Group; CKD = Chronic Kidney Disease; GFR = Glomerular Filtration Rate in ml/min/
1,73m2; METs = Metabolic Equivalents; Min = Minutes; RM = 1 Repetition Maximum; RPE = Borgs’ Rating of Perceived Exertion Scale; VT = at Ventilatory Treshold
(ml/kg/min)
a Power calculation was performed at 80%
b No power calculation was performed
https://doi.org/10.1371/journal.pone.0203662.t001
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poorer quality due to high heterogeneity (i.e. I275%) and blood pressure outcome was rated
of high risk for publication bias based on asymmetrical funnel plots (S1–S5 Fig).
Training-induced effects
Estimated glomerular filtration rate. Ten studies assessed eGFR as endpoint kidney
function parameter [1, 19–26, 28]. eGFR was obtained using the CKD-EPI creatinine equation
in three studies [22–24, 29] and the MDRD formula in seven studies [1, 16, 19–21, 25, 26, 28].
Nine RCTs compared aerobic exercise with standard care in, respectively, 151 and 154 partici-
pants over a mean period of 35 weeks [1, 19–24, 26, 28]. One study was excluded based on
incomplete reporting of data [25]. Duration of intervention varied between 12 weeks [22, 23,
26] and one year [1, 21, 24]. A calculated mean difference shows an improvement in eGFR of
2.16 ml/min per 1.73m2 [0.18; 4.13] (I2 = 50%) in participants allocated to aerobic exercise
compared to standard care (Fig 3). No significant within-group changes in eGFR were estab-
lished (Fig 4 and S6 Fig).
Blood pressure. Ten studies described the effect of aerobic exercise on blood pressure in
patients with CKD stages 3–4. For systolic and diastolic blood pressure, respectively, eight and
seven studies were included in the meta-analysis covering a total of 133 and 119 patients
receiving aerobic exercise compared to 136 and 118 control subjects [1, 19–22, 24, 26, 27].
Two and three studies were excluded for systolic [23, 25] and diastolic [21, 23, 25] blood pres-
sure analysis based on incomplete reporting of data respectively.
Blood pressure measurements took place in a sitting position after at least 5 minutes rest and
the average of 2 readings when pressures differed for less than 6 mmHg [19, 27] or of 3 readings
[19, 22, 24, 26, 30] was used. Protocol was not clearly stated in three studies [1, 20, 21].
Aerobic exercise training of a 32-week duration on average showed no effect on blood pres-
sure in the between-groups analysis (Fig 3). However, mean decreases in systolic blood pres-
sure of 5.20 mmHg [1.00; 9.4] (I2 = 15%) in patients assigned to aerobic exercise (Fig 4) and of
4.92 mmHg [1.10; 8.75] (I2 = 7%) in patients receiving standard care were obtained (S6 Fig).
Exercise tolerance. Ten studies examined exercise tolerance, as quantified by VO2peak in
CKD stages 3–4. These studies compared 161 participants receiving aerobic exercise with 164
control subjects [1, 19–26, 28]. Similarly, over an intervention period of on average 32 weeks,
meta-analysis of the VO2peak showed a within-group increase of 1.70 ml/kg/min [0.65; 2.74]
(I2 = 6%) amongst patients following aerobic exercise training (Fig 4). When compared to
standard care, aerobic training improved VO2peak by 2.39 ml/kg/min [0.99; 3.79] (I
2 = 90%)
(Fig 3).
Body mass index. Eight studies were included in the analysis of BMI covering 144
patients receiving on average 32 weeks aerobic exercise training compared to 150 control sub-
jects [1, 19, 21–24, 26, 27]. A decrease of 0.73 kg/m2 [-1.38; -0.09] (I2 = 54%) was found in
favour of the exercise group (S7 Fig).
Subgroup analyses. Analysis performed on changes in eGFR outcome with studies cate-
gorised mean age<60 or60 years old showed a difference disfavouring the elderly
(p = 0.004; I2 = 88%) (S8 Fig). Also a subgroup difference with mean BMI 32 kg/m2 as cut-off
point was noted (p<0.001; I2 = 92.2%); in favour of subjects scoring <32 kg/m2 (S9 Fig). Lee-
hey et al was excluded in the latter analysis due to a nutritional intervention in the control
group [21]. No subgroup differences were found when studies were divided based on interven-
tion duration and type (S10 and S11 Figs).
Fig 1. PRISMA flow diagram for the systematic review and meta-analysis.
https://doi.org/10.1371/journal.pone.0203662.g001
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Discussion
The purpose of this meta-analysis was to evaluate the effects of aerobic exercise training in
patients with CKD stages 3–4 on outcomes of cardiovascular and kidney function when com-
pared to standard care. We found that aerobic exercise improved eGFR (2.16 ml/min per
1.73m2), VO2peak (2.39 ml/kg/min) and decreased BMI (-0.73 kg/m
2) when compared to
Fig 2. Risk of bias.
https://doi.org/10.1371/journal.pone.0203662.g002
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standard care. In line with the most recent Cochrane review [11], aerobic exercise may thus be
beneficial for the CV risk profile. We did not find differences in blood pressure following an
aerobic training program compared to standard care. Hence, our study supports European
guidelines on physical exercise are also applicable in patients with CKD stages 3–4 [9].
Even though only two studies used exercise tolerance as primary outcome, it is not really
surprising to find an increase in VO2peak after an aerobic exercise intervention in patients
with CKD stages 3–4, as this effect is well established in other settings [31, 32]. We considered
an increase of 2.38 ml/min per kg (i.e. +10.9%) in VO2peak as clinically relevant based on a
minimal clinically important difference of 2 ml/min per kg or 6% reported in studies including
patients with other chronic diseases [33–35]. Also the accompanying improvements in global
and physical aspects of Quality of Life (four included studies assessing Quality of Life found
clinical relevant changes) indicated the improvement in VO2peak being of clinical relevance
[21, 25–27]. Aerobic training has been shown to effect several central and peripheral CV adap-
tations such as improved cardiac output, decreased peripheral vascular resistance, higher
blood volume, expanded capillary volume and increased peripheral O2-extraction, improving
maximal oxygen uptake [36], with shear stress as key factor in vascular adaptations [37]. It is
well documented that plasma volume expands up to 25% after 10–14 exercise sessions through
increased plasma albumin levels and sodium retention in sedentary healthy subjects. A sus-
tained 8–10% higher plasma compared to erythrocyte volume has also been noted after 30
days of training in sedentary people [38].
Sympathetic vasomotor over-activity is already present in the early stages of CKD and
might play a role in the further deterioration of kidney function [39, 40]. Aerobic exercise
restores surrogate parameters of sympathetic nervous system over-activity in patients with
Table 2. Quality assessment of outcome (GRADE).
Certainty Assessment № of Patients Effect Certainty Importance
(/9)№ of
Studies
Study
Design
Risk of
Bias
Inconsistency Indirectness or
Imprecision
Other Considerations Exercise
Group
Control
Group
Absolute
(95% CI)
Glomerular Filtration Rate
10 RCT + a + b - Strong Association 151 154 2.16 ml/kg per
1.73m2; [0.18;
4.13]
⊕⊕⊕◯
(Moderate)
Crucial (7)
Systolic Blood Pressure
8 RCT + a ++ c - Publication Bias
Strongly Suspected d
133 136 1.22 mmHg;
[-4.45; 6.90]
⊕◯◯◯ (Very
Low)
Not
Important (2)
Diastolic Blood Pressure
7 RCT + a ++ c - Publication Bias
Strongly Suspected d
119 118 0.06 mmHg;
[-3.22; 3.34]
⊕◯◯◯ (Very
Low)
Not
Important (2)
Exercise Tolerance
11 RCT + a ++ c - Strong Association 161 164 2.39 ml/kg per
min; [0.99; 3.79]
⊕⊕◯◯ (Low) Important (6)
Body Mass Index
8 RCT + a + b - Strong Association 144 150 -0.73 kg/m2;
[-1.38; -0.09]
⊕⊕⊕◯
(Moderate)
Important (6)
- = Not Serious; + = Serious; ++ = Very Serious; CI = Confidence Interval; RCT = Randomized Controlled Trials
a High risk for detection bias
b 25%<I2<75%
c I275%
d High risk for publication bias based on funnel plots
https://doi.org/10.1371/journal.pone.0203662.t002
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Fig 3. Forest plots between-groups analysis. (1) glomerular filtration rate (ml/min per 1.73m2), (2) systolic blood pressure (mmHg), (3) diastolic blood pressure
(mmHg) and (4) VO2peak (ml/kg/min).
https://doi.org/10.1371/journal.pone.0203662.g003
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CKD stages 3–4, possibly through stimulation of vascular and renal baroregulatory systems on
expanded blood volume [19, 41, 42]. Exercise training is a potential stimulus of vasodilation of
Fig 4. Forest plots within-group analysis (training group). (1) glomerular filtration rate (ml/min per 1.73m2), (2) systolic blood pressure (mmHg), (3) diastolic blood
pressure (mmHg) and (4) VO2peak (ml/kg/min).
https://doi.org/10.1371/journal.pone.0203662.g004
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the efferent renal arteriole in CKD, suggesting a downregulation of the renin-angiotensin sys-
tem [43]. Indeed, Cornelissen and Fagard reported a 20% lower plasma renin activity due to
aerobic exercise training in healthy sedentary normo- and hypertensive subjects [44].
Endothelial dysfunction is already present in early stages of CKD. The efferent renal arteri-
ole demonstrates a constriction in response to glomerular endothelial injury [45] and may
eventually contribute to further deterioration in eGFR and progression to renal microvascular
disease [46]. A late-onset decrease in oxidative stress and increase in anti-oxidative factors due
to exercise training could prevent progressive fibrosis in the kidneys [47, 48]. Exercise-induced
blood volume expansion likely contributes to increased renal blood flow and shear stress in the
kidney at rest and during exercise [49–51], the latter stimulating improvements in endothelial
function [52]. However, Van Craenenbroeck et al [26] and Headley et al [27] reported no effect
on flow-mediated dilation in patients with CKD stages 3–4 after a 12 and 16 weeks aerobic
training regimen respectively. As a possible explanation, the authors advance the relatively
short intervention period, which might not be enough to reverse established endothelial dys-
function. The results of this meta-analysis do not confirm a beneficial effect of aerobic exercise
training on eGFR as a proxy for kidney function (Fig 4). However, they support the hypothesis
that exercise might be beneficial in slowing down the progression CKD (Fig 3). Hence, as a
preventive strategy, aerobic exercise training might be useful in patients with CKD stages 3–4.
Blood pressure is recognized as a critical remediable aspect in the maintenance of kidney
function [37]. Hypertensive subjects experience a more substantial decrease in blood pressure
by exercise training than normotensive subjects; underlying mechanisms to this training effect
in (non-)healthy hypertensive subjects are improved vascular function (vascular remodelling
and endothelial function), decreased sympathetic vasomotor over-activity and downregulation
of the renin-angiotensin system [44]. However, the current meta-analysis did not show signifi-
cant alterations in blood pressure by aerobic exercise training [53]. Our results are in line with
the Cochrane review which reported no change in blood pressure following CV exercise. The
Cochrane review, however, found a decrease in systolic and diastolic blood pressure in studies
describing high intensity aerobic training (>60% VO2peak) and in studies combining aerobic
and resistance training [11]. This meta-analysis included one study with such intensities [20]
and four using combined exercise training [1, 19, 21, 24], and sensitivity analysis excluding
these citations did not alter results. Due to a generally well-controlled blood pressure (<140/
90 mmHg) at baseline [54], a great effect-size in blood pressure was not expected. Other possi-
ble explanations for the lack of significant change in blood pressure could be the use of and
change in antihypertensives masking training effects (i.e. only four studies described
unchanged medical therapy [22, 23, 25, 26]) and analysis being of low power since blood pres-
sure was examined as secondary outcome in included studies. An unexpected decrease in sys-
tolic blood pressure by standard care was observed.
A moderate and high degree of heterogeneity (I2 = 50% and I2 = 90%) was found in the
meta-analysis of eGFR and VO2peak respectively. Part of the heterogeneity in primary out-
come might be due to age as elderly experience a smaller training effect size compared to youn-
ger subjects [55, 56]. The three studies covering the oldest participants noted a lower effect size
on eGFR [1, 20, 21]. Analyses excluding these studies resulted in an improved eGFR of 3.43
ml/min per 1.73m2 [1.62; 5.23] with a negligible observed heterogeneity (I2<25%). Also exclu-
sion of the three studies with the highest mean BMI values [1, 19, 20] resulted in a negligible
heterogeneity and subgroup analyses showed favouring results for patients with better body
weight control. A detrimental correlation between BMI and oxidative stress in patients with
CKD stages 3–4 [57] could result in additional impairments of endothelial function ultimately
obliterating exercise training effects on eGFR. It must be noted that two of three studies with
mean BMI32 kg/m2 are among those covering the oldest participants [1, 20]. Heterogeneity
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can partially if not almost fully be explained by between-study differences in age and BMI.
Even though training modalities are determinants of treatment effects sizes for CV outcomes
in patients with CKD [52], nor analyses on training type and duration nor differences in super-
vision, frequency or intensity of training could explain the high heterogeneity. However, exclu-
sion of the four studies using both aerobic and resistance exercise training also resulted in a
negligible heterogeneity (I2 = 19%). Sensitivity analysis excluding studies which also included
patients with CKD stage 2 showed no alterations in effect size and heterogeneity (i.e. 2.16 ml/
min per 1.73m2; I2 = 50% in the current analysis vs. 2.98 ml/min per 1.73m2; I2 = 56% in the
sensitivity analysis for eGFR, p = 0.08 for subgroup analysis) [19–21].
It should be noted that muscle gain following physical exercise also affects eGFR measure-
ments as it increases serum creatinine levels, thereby decreasing eGFR based on equations
using creatinine. Hence, an exercise-induced increase in muscle mass may underestimate ben-
eficial effects on kidney function as absolute improvements in eGFR may have been more pro-
nounced than observed.
Quality and strength of evidence regarding VO2peak and blood pressure are low to very
low, mainly due to high risk of bias and heterogeneity. However, exclusion of articles scoring
high risk of bias on at least two different criteria did not alter the overall effect. The pooled
findings of change in eGFR following aerobic exercise were rated as of moderate strength.
Even though this article could have different conclusions than the Cochrane review, in par-
ticular because only RCTs including patients with CKD stages 3–4 were selected, similar find-
ings were retrieved for blood pressure and VO2peak [11].
Limitations
This review has some contextual limitations and reasonable risk of bias. Selective reporting
bias could result from retrospective registration of our protocol. Sedentary patients are less
likely to engage in exercise intervention trials, for this reason, selection bias can be a pitfall in
our meta-analysis, and results do thus not necessarily apply to the overall population with
CKD stages 3–4. No studies were included reporting measured GFR and two estimation equa-
tions for eGFR were used with a rather low correlation to measured methods (i.e. r = 0.41 for
the CKD-EPI and r = 0.27 for the MDRD) and to each other, inducing heterogeneity and addi-
tional bias [58]. Hydration status and muscle mass are undisputable confounders in the effects
of aerobic exercise training on eGFR and should be taken into account in future studies. Out-
come analyses were at risk of insufficient statistical power of individual studies since not more
than 3 included studies described a similar primary outcome. Heterogeneity could be overesti-
mated in our meta-analysis including only a small number of studies as we used the DerSimo-
nian-Laird method. However, this is the standard approach applied by Review Manager 5.3.5
[59].
Conclusions and guidelines for further research
This meta-analysis supports a beneficial effect of aerobic exercise on glomerular filtration rate
and exercise tolerance in patients with CKD stages 3–4 when compared to standard care.
Given the heterogeneous data, the lack of studies on hard and patient relevant endpoints, and
at best low to moderate methodological quality of studies, this meta-analysis should act as an
impetus for larger and more conclusive interventional research of high methodological quality
(e.g. by examining measured GFR as primary outcome and with hydration status as covariate).
Consensus regarding exercise prescription for this vulnerable population can only be reached
when the question about which frequency, intensity, type and time of exercise is of most bene-
fit, is answered.
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